ࡱ> 24/01_"bjbj4bb3KKKKK____|_[_0V^X^X^X^X^X^X^$`=cZ|^K|^KK_XXXKKV^XV^XX:x\,]+l9 \ B^+_0[_\Rc*Dc]]cK]X|^|^G6[_c? :"$ &/   % "%', /! " ,! % " !"  " # >4 73V4=> 7  021:2015:33690000-3 V:0@AL:V 70A>18 @V7=V (01>@0B>@=V @50:B828 ( 024:2019): 53307 "5AB 4;O :V;L:VA=>3> 287=0G5==O 3;N:>78 /Glucose HK Gen.3 (GLUC3), 53231 "5AB 4;O :V;L:VA=>3> 287=0G5==O 7030;L=>3> 2<VABC 1V;V@C1V=C, 250 B5ABV2/Bilirubin Total Gen.3, 53236 "5AB 4;O :V;L:VA=>3> 287=0G5==O ?@O<>3> 1V;V@C1V=C /Bilirubin-Direct (BIL-D2), 53989 "5AB 4;O 287=0G5==O 7030;L=>3> 2<VABC 1V;:C /TP2/Total Protein Gen.2 ,53590 "5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>28=8/ 07>BC A5G>28=8 /(UREA), 53252 "5AB 4;O :V;L:VA=>3> 287=0G5==O :@50B8=8=C /Creatinine Jaff Gen.2 (700 tests), 53362 "5AB 4;O 287=0G5==O 7030;L=>3> E>;5AB5@8=C /CHOL HiCo Gen.2, cobas c, Int., 53462 "5AB 4;O :V;L:VA=>3> 287=0G5==O B@83;VF5@84V2 /Triglycerides (TRIGL), 53393 "5AB 4;O :V;L:VA=>3> 287=0G5==O E>;5AB5@8=C-), Gen.4 , 53412 "5AB 4;O 287=0G5==O )-E>;5AB5@8= 3 ?>:>;V==O (200 B5ABV2), 52925 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0;0=V=0<V=>B@0=AD5@078 (") /Alanine Aminotransferase acc. to IFCC (ALTL), 52955 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0A?0@B0B0<V=>B@0=AD5@078(!") /Aspartate Aminotransferase acc. to IFCC (ASTL), 52941 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0;LD0-0<V;078 /AMYL2/ alpha-Amylase EPS ver.2, 38502 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0;LD0-0<V;078 ?V4H;C=:>2>W 70;>78 /alpha-Amylase EPS Pancreatic (AMY-P), 52929 "5AB 4;O :V;L:VA=>3> 287=0G5==O ;C6=>W D>AD0B078, 400 B5ABV2 /Alkaline Phosphatase acc. to IFCC Gen.2 ALP2L, 53030 "5AB 4;O 287=0G5==O 30<<0-3;CB0<V;B@0=AD5@078 /GGT gamma-Glutamyltransferase ver.2 , 38512 "5AB 4;O :V;L:VA=>3> 287=0G5==O :0B0;VB8G=>W 0:B82=>ABV :@50B8=:V=078 MB-D@0:FVW CKMB2, 38512 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0:B82=>ABV :@50B8=:V=078, 200 B5ABV2, 53586 "5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>2>W :8A;>B8 /UA2/Uric Acid ver.2 , 52875 "5AB 4;O :V;L:VA=>3> 287=0G5==O :0;LFVN (300 B5ABV2) /Calcium Gen.2 (300 tests), 54762 "5AB 4;O :V;L:VA=>3> 287=0G5==O 70;V70 /IRON2/Iron Gen.2 , 53908 "5AB 4;O :V;L:VA=>3> 287=0G5==O =5=0A8G5=>W 70;V7>72 O7CNG>W 740B=>ABV A8@>20B:8 :@>2V B0 ?;07<8 /UIBC Unsaturated Iron-Binding Capacity, 52883 "5AB 4;O :V;L:VA=>3> 287=0G5==O <03=VN, 25@ 2, 250 B5ABV2 / Magnesium Gen.2 250 tests), 52891 "5AB 4;O :V;L:VA=>3> 287=0G5==O =5>@30=VG=>3> D>AD0BC /PHOS2/Phosphate (Inorganic) ver.2, 53599 "5AB 4;O 287=0G5==O :>=F5=B@0FVW 0;L1C<V=C /ALB BCG Gen.2, cobas c, Int., 53719 "5AB 4;O :V;L:VA=>3> 287=0G5==O D5@8B8=C (250 B5ABV2) / Tina-quant Ferritin Gen.4 250 tests), 53994 "5AB 4;O :V;L:VA=>3> 287=0G5==O B@0=AD5@V=0 /TRSF Tina-quant Transferrin ver.2, 53316 "5AB 4;O :V;L:VA=>3> 287=0G5==O 35<>3;>1V=C /Tina-quant Hemoglobin A1c Gen.3, 47349 "5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>4C:BV2 @>7?04C DV1@8=V2 (100 B5ABV2) /Tina-quant D-Dimer Gen.2 (100 tests), 53707 "5AB 4;O :V;L:VA=>3> 287=0G5==O !-@50:B82=>3> 1V;:0 (CRP), 4 35=., cobas c 311/501/502, Integra, 55113 "5AB 4;O :V;L:VA=>3> 287=0G5==O @52<0B>W4=>3> D0:B>@C /Rheumatoid Factors II (RF-II), 37756 "5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> AB@5?B>;V78=C  / ASLO" Tina-quant Antistreptolysin O, 47869 >=B@>;L Precicontrol Clinchem 1 (4x5<;) /Precicontrol Clinchem 1 (4x5ml), 47869 >=B@>;L Precicontrol Clinchem 2 (4x5<;) /Precicontrol Clinchem 2 (4x5ml), 52869 >7G8= 4;O @5D5@5=B=>3> 5;5:B@>40 /ISE Reference Electrolyte, 58237 ISE @>7102;N20G 4;O :V;L:VA=>3> 287=0G5==O =0B@VN, :0;VN, E;>@84C 2 A8@>20BFV, ?;07<V 01> A5GV, 52869 ISE AB0=40@B 2=CB@VH=V9 4;O :V;L:VA=>3> 287=0G5==O =0B@VN, :0;VN, E;>@84C 2 A8@>20BFV, ?;07<V 01> A5GV, 58236 @><82=89 @>7G8= NaOHD 4;O ?@>1 @5035=BC B0/01> @50:FV9=8E :0<5@ 2 A8AB5<0E Roche/Hitachi cobas c, 58237 >102:0 4;O 7=865==O ?>25@E=52>3> =0BO3C 2 @50:FV9=>W 20==V 0=0;V70B>@0 cobas c 311, 58236 @><82=89 @>7G8= Cell wash Solution I/NaOH-D, 61165 5<>;V7CNG89 @5035=B, 51 <; /H1CD2 Hemolyzing Reagent Gen.2, 54386 "5AB-A8AB5<0 4;O 287=0G5==O B8@5>B@>?=>3> 3>@<>=C 2 35=., 54413 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =572'O70=>3> B8@>:A8=C, gen.III, 54417 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> B@89>4BV>=V=C /FT3 Gen.3, 54084 "5AB-A8AB5<0 4;O 287=0G5==O :0;LF8B>=V=C, 58728 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>3;>1C;V=C, 25@ 4 /Anti-Tg Gen.4, 58729 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>?5@>:A84078, 25@. 3 /Anti-TPO Gen.3, 54484 "5AB 4;O :V;L:VA=>3> 287=0G5==O 7030;L=>3> 25-3V4@>:A82VB0<V=C D /Vitamin D total, 54237 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O V=AC;V=C /Insulin, 54004 "5AB 4;O :V;L:VA=>3> 287=0G5==O A5@45G=>3> B@>?>=V=C ", 25@.2, 200 B5ABV2, 58731 "5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>:0;LF8B>=V=C, 100 HB, 25@.2, 54665 01V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O :>=F5=B@0FVW 7030;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (Total PSA), 48323 01V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O ?>25@E=52>3> 0=B835=C 2V@CAC 35?0B8BC B II (HBsAg II), 48366 01V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O 0=B8BV; 4> 2V@CAC 35?0B8BC ! (Anti-HCV II), 53858 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =B5@;59:V=0-6 (-6) /IL-6, 58236 !8AB5<=89 @>7G8= 4;O 35=5@0FVW 5;5:B@>EV<VG=8E A83=0;V2 2 V<C=>0=0;V70B>@0E Elecsys, cobas e, 59058 !8AB5<=89 @>7G8= 4;O G8AB:8 45B5:B>@=>3> 1;>:C, Elecsys, cobas e, 58236 >7G8= Elecsys Sys Wash, 61032 >2?0G>: (@50:FV9=0 ?@>1V@:0) 4;O 28:>@8AB0==O 2 A8AB5<0E cobas e 411/Elecsys 2010, 16822 0:V=5G=8: 4;O 28:>@8AB0==O 2 A8AB5<0E cobas e 411/Elecsys 2010, 61032 @>1V@:0 4;O 7@07:V2, 58237 >7G8==8: C=V25@A0;L=89 /Universal Diluent, 54670 01V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA), 38183 0;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA) A=>2=V 28<>38 4> ?@54<5BC 70:C?V2;V: 1. ">20@ ?>28=5= <0B8 4>:C<5=B8, I> ?V4B25@46CNBL ?@>2545==O >FV=:8 2V4?>2V4=>ABV 70?@>?>=>20=>3> B>20@C 28<>30< B5E=VG=>3> @53;0<5=BC(=040B8 :>?VN 45:;0@0FVW 2V4?>2V4=>ABV 01> :>?VN A5@B8DV:0B0 2V4?>2V4=>ABV) # @07V O:I> B>20@ ?V4;O30T @5TAB@0FVW. /:I> B>20@ =5 ?V4;O30T @5TAB@0FVW, =5>1EV4=> =040B8 ;8AB-?>OA=5==O 7 ?>A8;0==O< =0 =>@<0B82=>-?@02>2V 0:B8 B0 >1@C=BC20==O< =5=040==O =5>1EV4=8E 4>:C<5=BV2. 2. "5@<V= ?@840B=>ABV B>20@C =0 <><5=B ?>AB02:8 ?>28=5= A:;040B8 =5 <5=H5 60 % 2V4 7030;L=>3> B5@<V=C ?@840B=>ABV. >AB0G0==O B>20@C 7 <5=H8< B5@<V=>< ?@840B=>ABV 74V9A=NTBLAO 70 ?>3>465==O< !B>@V=. #G0A=8: =040T 30@0=BV9=89 ;8AB ?@> ?>AB02:C B>20@C 7 2V4?>2V4=8< B5@<V=>< ?@840B=>ABV. !>4  024:201909<5=C20==O48=8FO 28<V@C$0AC20==OV;L:VABL153307"5AB 4;O :V;L:VA=>3> 287=0G5==O 3;N:>78 /Glucose HK Gen.3 (GLUC3)HB800 B5ABV214253231"5AB 4;O :V;L:VA=>3> 287=0G5==O 7030;L=>3> 2<VABC 1V;V@C1V=C, 250 B5ABV2n\ v  mW?+?+?+?+&h9|h9|5OJPJQJ\nHtH.h9|h9|5OJPJQJ\mH"nHsH"tH+h9|h9|5OJPJQJmH"nH"sH"tH"+h9|h55OJPJQJmH"nH"sH"tH"'h9|h55OJQJmH"nHsH"tH'h9|h55OJQJmH"nHsH"tH*h9|h55OJQJmHnHsH"tH"uh9|h55OJQJmH"sH"*h]\O5B*CJOJQJaJmH"phsH"0hZvh]\O5B*CJOJQJaJmH"phsH"h4j447 :":&:F:`:~:::$d$Ifa$gd3$d$Ifa$gds $da$gd0 $da$gdiH$d`a$gd0]gd5 dgd9| $]a$gd]\O    J \ ^ j n t v x |    $ " * . 4 D N P ` b|  .0PR&h9|h9|5OJPJQJ\nHtH+h9|h9|5OJPJQJmH"nH"sH"tH".h9|h9|5OJPJQJ\mH"nHsH"tHKRX\`bjnvx:<BFJLTX`br v>DFPRxzԾԾԾԾ+h9|h9|5OJPJQJmH"nH"sH"tH".h9|h9|5OJPJQJ\mH"nHsH"tH&h9|h9|5OJPJQJ\nHtHK"&8@BRLPT\^fhnt"$4|Pbdjx  $6:@DTѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽѽ&h9|h9|5OJPJQJ\nHtH.h9|h9|5OJPJQJ\mH"nHsH"tH+h9|h9|5OJPJQJmH"nH"sH"tH"Jdlnxz (*46LNT\hlrBVXfhlptvzԾ+h9|h9|5OJPJQJmH"nH"sH"tH"&h9|h9|5OJPJQJ\nHtH.h9|h9|5OJPJQJ\mH"nHsH"tHKz|     & ( H J L \ n !(!*!:!D!F!R!j!l!|!!!!!!!!!!""""(".""""####h$r$t$$ҾҾ.h9|h9|5OJPJQJ\mH nHsH tH&h9|h9|5OJPJQJ\nHtH+h9|h9|5OJPJQJmH"nH"sH"tH".h9|h9|5OJPJQJ\mH"nHsH"tHA$$$$$$2%<%>%@%H%X%z%%%%%%%%%%%%%%%%&&&&*&,&2&6&F&&&@'F'H'N'^'''''''J(Z((((((())))))))Ծ覾Ծ.h9|h9|5OJPJQJ\mH nHsH tH+h9|h9|5OJPJQJmH"nH"sH"tH"&h9|h9|5OJPJQJ\nHtH.h9|h9|5OJPJQJ\mH"nHsH"tHA)))P*R*V*d*f*h*j*t****+++,.,N,\,- ----&-F-T----------. ...........3> 287=0G5==O ?@O<>3> 1V;V@C1V=C /Bilirubin-Direct (BIL-D2)HB350 B5ABV232453989"5AB 4;O 287=0G5==O 7030;L=>3> 2<VABC 1V;:C /TP2/Total Protein Gen.2 HB300 B5ABV236553590"5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>28=8/ 07>BC A5G>28=8 /(UREA)HB500 B5ABV224653252"5AB 4;O :V;L:VA=>3> 287=0G5==O :@50B8=8=C /Creatinine Jaff Gen.2 (700 tests)HB700 B5ABV217753362"5AB 4;O 287=0G5==O 7030;L=>3> E>;5AB5@8=C /CHOL HiCo Gen.2, cobas c, Int.HB400 B5ABV224853462"5AB 4;O :V;L:VA=>3> 287=0G5==O B@83;VF5@84V2 /Triglycerides (TRIGL)HB250 B5ABV216953393"5AB 4;O :V;L:VA=>3> 287=0G5==O E>;5AB5@8=C-), Gen.4 HB350 B5ABV2121053412"5AB 4;O 287=0G5==O )-E>;5AB5@8= 3 ?>:>;V==O (200 B5ABV2)HB200 B5ABV2201152925"5AB 4;O :V;L:VA=>3> 287=0G5==O 0;0=V=0<V=>B@0=AD5@078 (") /Alanine Aminotransferase acc. to IFCC (ALTL)HB500 B5ABV2241252955"5AB 4;O :V;L:VA=>3> 287=0G5==O 0A?0@B0B0<V=>B@0=AD5@078(!") /Aspartate Aminotransferase acc. to IFCC (ASTL)HB500 B5ABV2241352941"5AB 4;O :V;L:VA=>3> 287=0G5==O 0;LD0-0<V;078 /AMYL2/ alpha-Amylase EPS ver.2HB300 B5ABV2281438502"5AB 4;O :V;L:VA=>3> 287=0G5==O 0;LD0-0<V;078 ?V4H;C=:>2>W 70;>78 /alpha-Amylase EPS Pancreatic (AMY-P)HB200 B5ABV281552929"5AB 4;O :V;L:VA=>3> 287=0G5==O ;C6=>W D>AD0B078, 400 B5ABV2 /Alkaline Phosphatase acc. to IFCC Gen.2 ALP2LHB400 B5ABV281653030"5AB 4;O 287=0G5==O 30<<0-3;CB0<V;B@0=AD5@078 /GGT gamma-Glutamyltransferase ver.2 HB400 B5ABV221738512"5AB 4;O :V;L:VA=>3> 287=0G5==O :0B0;VB8G=>W 0:B82=>ABV :@50B8=:V=078 MB-D@0:FVW CKMB2HB100 B5ABV281838512"5AB 4;O :V;L:VA=>3> 287=0G5==O 0:B82=>ABV :@50B8=:V=078, 200 B5ABV2HB200 B5ABV221953586"5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>2>W :8A;>B8 /UA2/Uric Acid ver.2 HB400 B5ABV282052875"5AB 4;O :V;L:VA=>3> 287=0G5==O :0;LFVN (300 B5ABV2) /Calcium Gen.2 (300 tests)HB300 B5ABV2102154762"5AB 4;O :V;L:VA=>3> 287=0G5==O 70;V70 /IRON2/Iron Gen.2 HB200 B5ABV242253908"5AB 4;O :V;L:VA=>3> 287=0G5==O =5=0A8G5=>W 70;V7>72 O7CNG>W 740B=>ABV A8@>20B:8 :@>2V B0 ?;07<8 /UIBC Unsaturated Iron-Binding CapacityHB100 B5ABV282352883"5AB 4;O :V;L:VA=>3> 287=0G5==O <03=VN, 25@ 2, 250 B5ABV2 / Magnesium Gen.2 250 tests)HB250 B5ABV242452891"5AB 4;O :V;L:VA=>3> 287=0G5==O =5>@30=VG=>3> D>AD0BC /PHOS2/Phosphate (Inorganic) ver.2HB250 B5ABV222553599"5AB 4;O 287=0G5==O :>=F5=B@0FVW 0;L1C<V=C /ALB BCG Gen.2, cobas c, Int.HB300 B5ABV242653719"5AB 4;O :V;L:VA=>3> 287=0G5==O D5@8B8=C (250 B5ABV2) / Tina-quant Ferritin Gen.4 250 tests)HB250 B5ABV242753994"5AB 4;O :V;L:VA=>3> 287=0G5==O B@0=AD5@V=0 /TRSF Tina-quant Transferrin ver.2 HB100 B5ABV212853316"5AB 4;O :V;L:VA=>3> 287=0G5==O 35<>3;>1V=C /Tina-quant Hemoglobin A1c Gen.3 HB150 B5ABV2122947349"5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>4C:BV2 @>7?04C DV1@8=V2 (100 B5ABV2) /Tina-quant D-Dimer Gen.2 (100 tests)HB100 B5ABV213053707"5AB 4;O :V;L:VA=>3> 287=0G5==O !-@50:B82=>3> 1V;:0 (CRP), 4 35=., cobas c 311/501/502, IntegraHB250 B5ABV2123155113"5AB 4;O :V;L:VA=>3> 287=0G5==O @52<0B>W4=>3> D0:B>@C /Rheumatoid Factors II (RF-II)HB100 B5ABV2123237756"5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> AB@5?B>;V78=C  / ASLO" Tina-quant Antistreptolysin OHB150 B5ABV283347869>=B@>;L Precicontrol Clinchem 1 (4x5<;) /Precicontrol Clinchem 1 (4x5ml)=01V@4 E 5 <; 13447869>=B@>;L Precicontrol Clinchem 2 (4x5<;) /Precicontrol Clinchem 2 (4x5ml)=01V@4 E 5 <; 13552869 >7G8= 4;O @5D5@5=B=>3> 5;5:B@>40 /ISE Reference Electrolyte =01V@5 E 300 <; 13658237ISE @>7102;N20G 4;O :V;L:VA=>3> 287=0G5==O =0B@VN, :0;VN, E;>@84C 2 A8@>20BFV, ?;07<V 01> A5GV=01V@5 E 300 <; 13752869ISE AB0=40@B 2=CB@VH=V9 4;O :V;L:VA=>3> 287=0G5==O =0B@VN, :0;VN, E;>@84C 2 A8@>20BFV, ?;07<V 01> A5GV=01V@5 E 600 <; 53858236@><82=89 @>7G8= NaOHD 4;O ?@>1 @5035=BC B0/01> @50:FV9=8E :0<5@ 2 A8AB5<0E Roche/Hitachi cobas cHB58,7 <; 123958237>102:0 4;O 7=865==O ?>25@E=52>3> =0BO3C 2 @50:FV9=>W 20==V 0=0;V70B>@0 cobas c 311HB55,9 <; 164058236@><82=89 @>7G8= Cell wash Solution I/NaOH-D=01V@2 E 1800 <; 441611655<>;V7CNG89 @5035=B, 51 <; /H1CD2 Hemolyzing Reagent Gen.2HB51 <; 14254386"5AB-A8AB5<0 4;O 287=0G5==O B8@5>B@>?=>3> 3>@<>=C 2 35=.HB200 B5ABV2124354413<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =572'O70=>3> B8@>:A8=C, gen.IIIHB200 B5ABV244454417<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> B@89>4BV>=V=C /FT3 Gen.3HB200 B5ABV224554084"5AB-A8AB5<0 4;O 287=0G5==O :0;LF8B>=V=CHB100 B5ABV224658728<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>3;>1C;V=C, 25@ 4 /Anti-Tg Gen.4HB100 B5ABV214758729<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>?5@>:A84078, 25@. 3 /Anti-TPO Gen.3HB100 B5ABV284854484"5AB 4;O :V;L:VA=>3> 287=0G5==O 7030;L=>3> 25-3V4@>:A82VB0<V=C D /Vitamin D totalHB100 B5ABV244954237<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O V=AC;V=C /InsulinHB100 B5ABV225054004"5AB 4;O :V;L:VA=>3> 287=0G5==O A5@45G=>3> B@>?>=V=C ", 25@.2, 200 B5ABV2 HB200 B5ABV225158731"5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>:0;LF8B>=V=C, 100 HB, 25@.2=01V@100 B5ABV21525466501V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O :>=F5=B@0FVW 7030;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (Total PSA)HB100 B5ABV24534832301V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O ?>25@E=52>3> 0=B835=C 2V@CAC 35?0B8BC B II (HBsAg II)HB100 B5ABV212544836601V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O 0=B8BV; 4> 2V@CAC 35?0B8BC ! (Anti-HCV II)=01V@100 B5ABV235553858<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =B5@;59:V=0-6 (-6) /IL-6HB100 B5ABV225658236!8AB5<=89 @>7G8= 4;O 35=5@0FVW 5;5:B@>EV<VG=8E A83=0;V2 2 V<C=>0=0;V70B>@0E Elecsys, cobas e=01V@6 E 380 <; 125759058!8AB5<=89 @>7G8= 4;O G8AB:8 45B5:B>@=>3> 1;>:C, Elecsys, cobas e =01V@6 E 380 <; 125858236 >7G8= Elecsys Sys WashHB1 E 500 <; 25961032>2?0G>: (@50:FV9=0 ?@>1V@:0) 4;O 28:>@8AB0==O 2 A8AB5<0E cobas e 411/Elecsys 2010?0:>260 E 60260168220:V=5G=8: 4;O 28:>@8AB0==O 2 A8AB5<0E cobas e 411/Elecsys 2010?0:>230 E 120 46161032@>1V@:0 4;O 7@07:V2 ?0:>25000 HB16258237 >7G8==8: C=V25@A0;L=89 /Universal Diluent=01V@2 E 36 <; 1635467001V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA)HB100 B5ABV2164381830;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA)=01V@4 x 1.0 <; 1 p;.X4XJXPX$d$Ifa$gdsd$Ifgd3PXRXVXbX/$d$Ifa$gdskd $$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsbXXYY Y$d$Ifa$gdsd$Ifgd3 Y"Y&Y2Y/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts2YYYYY$d$Ifa$gdsd$Ifgd3YYYY/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsYtZzZZZ$d$Ifa$gdsd$Ifgd3ZZZZ/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsZF[L[b[h[$d$Ifa$gdsd$Ifgd3h[j[n[z[/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsn[z[2\4\8\D\\\\]]]]]F^H^N^Z^R_T_Z_f_d`f`l`x`6a8a>aJa:baJa/$d$Ifa$gdskdA $$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsJab b6b:b$d$Ifa$gdsd$Ifgd3:bgTgZg$d$Ifa$gdsd$Ifgd3Zg\gbgng/$d$Ifa$gdskdd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsnggggh$d$Ifa$gdsd$Ifgd3hh hh/$d$Ifa$gdskdi$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsh*i0iFiJi$d$Ifa$gdsd$Ifgd3JiLiRi^i/$d$Ifa$gdskdn$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts^i jj(j,j$d$Ifa$gdsd$Ifgd3^i,j.j4j@jkkk&kkkkkllllmmmmnnpnvnn~oooo~pppp^q`qfqrqTrVr\rhrxrrrr s"s(s4sDs~sssssԺԺԺԺԺԺԺԺԺԺԺ3hshsCJOJPJQJ\aJmH nHsH tH(hshsCJOJPJQJaJnH"tH"3hshsCJOJPJQJ\aJmH"nHsH"tH(hshsCJOJPJQJaJnHtH+hshsCJOJPJQJ\aJnHtH6,j.j4j@j/$d$Ifa$gdskds$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts@jjjkk$d$Ifa$gdsd$Ifgd3kkk&k/$d$Ifa$gdskdx$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts&kkkkk$d$Ifa$gdsd$Ifgd3kkkk/$d$Ifa$gdskd}$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytskllll$d$Ifa$gdsd$Ifgd3llll/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytslzmmmm$d$Ifa$gdsd$Ifgd3mmmm/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsmLnRnhnnn$d$Ifa$gdsd$Ifgd3nnpnvnn/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsn^odozo~o$d$Ifa$gdsd$Ifgd3~oooo/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytso\pbpxp~p$d$Ifa$gdsd$Ifgd3~pppp/$d$Ifa$gdskd$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytspyLyVyZyyyyyy\z^zdzpz{{"{.{{{{{b|d|ккккккккккк3hshsCJOJPJQJ\aJmH nHsH tH(hshsCJOJPJQJaJnHtH+hshsCJOJPJQJ\aJnHtH(hshsCJOJPJQJaJnH"tH"3hshsCJOJPJQJ\aJmH"nHsH"tH6t|tttt$d$Ifa$gdsd$Ifgd3tttt/$d$Ifa$gdskd#$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytstvuuuu$d$Ifa$gdsd$Ifgd3uuuu/$d$Ifa$gdskd$$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsuvvvv$d$Ifa$gdsd$Ifgd3vvvv/$d$Ifa$gdskd%$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsvwwww$d$Ifa$gdsd$Ifgd3wwww/$d$Ifa$gdskd&$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytswZx`xrxxx$d$Ifa$gdsd$Ifgd3xxzxxx/$d$Ifa$gdskd'$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsxxx yy$d$Ifa$gdsd$Ifgd3yyy$y/$d$Ifa$gdskd($$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts$yyyyy$d$Ifa$gdsd$Ifgd3yyyy/$d$Ifa$gdskd)$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsy:z@zVz\z$d$Ifa$gdsd$Ifgd3\z^zdzpz/$d$Ifa$gdskd*$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytspzz{{{$d$Ifa$gdsd$Ifgd3{{"{.{/$d$Ifa$gdskd+$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts.{{{{{$d$Ifa$gdsd$Ifgd3{{{{/$d$Ifa$gdskd,$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts{B|H|^|b|$d$Ifa$gdsd$Ifgd3b|d|j|v|/$d$Ifa$gdskd-$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsd|j|v|@}B}H}T}&~(~.~:~~jlr~"$*6@BHTBDJV24:F кккккккккккккккк(hshsCJOJPJQJaJnHtH+hshsCJOJPJQJ\aJnHtH(hshsCJOJPJQJaJnH"tH"3hshsCJOJPJQJ\aJmH"nHsH"tHAv| }&}<}@}$d$Ifa$gdsd$Ifgd3@}B}H}T}/$d$Ifa$gdskd.$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsT}~ ~"~&~$d$Ifa$gdsd$Ifgd3&~(~.~:~/$d$Ifa$gdskd/$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts:~~~~~$d$Ifa$gdsd$Ifgd3~/$d$Ifa$gdskd0$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd1$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsJPfj$d$Ifa$gdsd$Ifgd3jlr~/$d$Ifa$gdskd2$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts~"$d$Ifa$gdsd$Ifgd3"$*6/$d$Ifa$gdskd3$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts6 &<@$d$Ifa$gdsd$Ifgd3@BHT/$d$Ifa$gdskd5$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsT &<B$d$Ifa$gdsd$Ifgd3BDJV/$d$Ifa$gdskd 6$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsV .2$d$Ifa$gdsd$Ifgd324:F/$d$Ifa$gdskd7$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsFȄ΄$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd8$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts…څ$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd9$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsx$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd:$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts$d$Ifa$gdsd$Ifgd3 /$d$Ifa$gdskd";$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsćЇ$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd'<$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsz$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd,=$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsވ$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd1>$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsxh9|h<mH"sH"h9|h]\OmH"sH"/hGrCJOJQJaJfHmH"q sH"3hshsCJOJPJQJ\aJmH"nHsH"tH(hshsCJOJPJQJaJnHtH+hshsCJOJPJQJ\aJnHtH(hshsCJOJPJQJaJnH"tH"ht$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd6?$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytslr$d$Ifa$gdsd$Ifgd3/$d$Ifa$gdskd;@$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<ytsdp$d$Ifa$gdsd$Ifgd3/*%gd]\Ogddkd@A$$IfֈrcL"%FeF?FBB tL&62 24 4Bap<yts21h:p<. A!"R#n$n% $$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<yts$$If!vh#v#ve#v?#v#v-#vr:V  tL&655e5?55/ 2 244Bap<ytsj 666666666vvvvvvvvv666666>666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH"nH"sH"tH"L`L ]\O1KG=K9 dCJ_HaJmHsHtH BA B A=>2=>9 H@8DB 0170F0Xi@X 01KG=0O B01;8F04 l4a .k . 0 5B A?8A:0 lT@l ]\O&8B0B0*$d]^`a$CJOJQJaJmH"sH"tH~O~ !1KG=K9 (251),1KG=K9 (Web) =0: =0: =0:,1KG=K9 (Web) =0: =0: =0: =0: =0: =0:,1KG=K9 (Web) =0: =0: =0: =0:,1KG=K9 (Web) =0: =0: =0:1 =0: =0: =0: =0: =0: =0: =0: = =0: =0: =0:,1KG=K9 (251) =0: =0:1,1KG=K9 (251) =0: =0:Wd$d%d&d'd*$NOPQOJPJQJaJtH"D/D !A=>2=>9 H@8DB 0170F02PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VCWNIA!ޝ}7/݉%BR7Hw9!p<Ǥፉ.EB\ /T*Y>,cy'$gC."Vso+C1OǓt}8>V3mBb%DWs'O''Gw ~lh;UM!DzŬ;C K^ysJJ1KRμ)~.ک/ Y\n9?[]67)qnpJOF$ w;fCLL&׸m%]V%z-{ v8Ҩm-.xo(-ms~ۜ|s>Ͼ%O04h=یщ!eƌ\f :C*OiIA 64HpUa7 UO3 d:(fA@٣>N"Hhp&hA38 )SUUR'V5&HM.6xpyn,ބ!h^^Z4~0#w,,& g"Ic힍Q)˕C6%^+Hk!$A*#.D)irdq8Y^}q~C>Np%uJx?+al|zf[Ux5b>c!:M (MkIVEpYPҍN2$ÿ -.h۴"P6T{T 6]u̒VhVnR+n;)ȔbL X6Y`+qB]( 0H1$6_[s)k8Tm Aa?R d ڒɾ0{eRF& Ī't\{BHuM6`pGϽO+!XoN'^[crh2*tW<{1U+l_QSncX<)Q(wJH ٯ#zCm>nhf6t}M&ʺ6ײ'\gkNS:;\qN-S;kǺ"{DailL`̗/޿ ^o#I&%0]SPV!] PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!^}-theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] 3  Rz$)`17n[^isd| !"#$%&'(Pr::^;p;PXbX Y2YYYZZh[z[2\D\\]]]F^Z^R_f_d`x`6aJa:bNbFcZc"d6deeeeffZgnghhJi^i,j@jk&kkkllmmnnn~oo~pp^qrqTrhr s4sstttuuvvwwxxxy$yyy\zpz{.{{{b|v|@}T}&~:~~j~"6@TBV2F)*+FGHIJKLMNOQRSTUVWXYZ[\]^_`abcdefghijklmnopqstuvwxyz{|}~8@0(  B S  ?T]^cdgz"/1>(),.0d|QVW^cm#()<=@*./347yCNOST[\d     ^ a e j n q      & ' * b f g l m w |  E J [ b    $ 7 C D L X d e m   # 49:ABG ?Lcl%-6]kmptxy{|+25:BKqx'.bvNRbk>EGL]dehim MVW^v} *.#/078>?HIRepq{|  $:EFPYceu !)1:<AG]hist~ +67ABOQ^gint 6ABLMckrs  !#(.EPQ[bir 0;<FGMNW]cemnyz}    $ / 0 : ; G H R S ` d k r t y  ! ! !!!! !$!%!)!1!3!8!>!T!_!`!j!l!s!y!!!!!!!!!!!!!!!!!!!!!!"" "*","7"8"H"I"R"S"\"]"b"f"l"s"~""""""""""""""""""""### ##)#4#5#?#@#M#]#f#h#q#y#{################## $ $$$$$$*$.$8$9$A$L$Q$S$U$Z$`$v$$$$$$$$$$$$$$$$$$$%%%%%&%(%-%3%J%U%V%`%a%j%k%r%s%{%%%%%%%%%%%%%%%%%%%&&&&-&.&0&5&;&R&]&^&h&i&v&&&&&&&&&&&&&&&&&&'''''!'''='I'J'R'^'j'k's'~''''''''''''(( (((!('(0(1(<(>(C(`(k(p({(|((((((((((((((((((()) ) ))))%).)0)6)7):);)?)@)E)^)g)h)n)o)t)))))))))))))))))***** *!*&*-*/*F*O*P*V*l*p*s*x*********++$+*+8+A+F+Q+R+\+]+i+u+|+}++++++++++++++++++ ,,, ,!,#,(,.,;,D,I,T,U,_,`,g,k,y,,,,,,,,,,,,,,,,,,,-- --&-1-2-<-=-G-_-f-i-n-o-q-v-|-------------------...#.%.'.,.2.H.S.T.^._.n.t.v.~..................../ /////*///0/9/:/A/F/N/O/Y/Z/f/p/v///////////////////////0 000#0,010<0=0G0d0f0k0q0~000000000000000000011 1*1113181<1A1[1a1b1i1j1m1n1r1s1u111111111111112 22$2)20272Y2a2f2m2z2|2222222222222222222233 3 3!3,3036383=3C3P3^3_3d3i3t3u33333333333X[.{}LME 35Z[TVad#$)+[\:<FGLNY\ '*gisty{$&!#-.35AD  ,/     # r t ~  1!3!=!>!B!D!P!S!!!!!!!!!!!"""""""""#######%#(#y#{#############S$U$_$`$d$f$r$u$$$$$$$$$&%(%2%3%8%:%F%I%%%%%%%%%.&0&:&;&@&B&N&Q&&&&&&&&&''&'''+'-'''''''''B(C(S(U(l(o((((((((( ))D)E)U)W)))))-*/*=*?*w*x*******++)+*+/+1+B+E+}++++++++++++++!,#,-,.,2,4,,,,,,,------"-%-o-q-{-|---------..%.'.1.2.6.8.t.v.........////!/#/./////////// 0 00000d0f0p0q0u0w00000001"1@1A1R1T1s1u11111P2R2l2m2z2|2222222226383B3C3G3I3c3d3333\1:T"g-!< '  r 1!K!!!! """# #y####S$m$$$&%A%%%.&I&&&'4'~'''''''(>(O(P(\(((((@)Q)R)^)))))-*8*9*F*s********+8+}++++!,;,,,--o----%.?.~../*///0#0d0~00000<1M1N111111=222263P33333333XY  T]^cdgikpq  MQRTYZ1>@EFHMN(),.0157;<>CD QVW^_bcmorstuw|}"#()<=@CEJK&(*./347:<ABy>BCNOST[\fkl       " $ ) * V Y Z ] ^ a e j k l n q r t y z       & ' * , . 3 4 b f g l m w x y z { |  6 9 E J K L [ d i j      $ % ( - . 7 C D L Q R X d e m r s t v w y ~      r t y } 49:ABGHKPQ "#[]bc%',-txy{|()+2345<ABqz'.NRSVWYZ\ab >EGLMPUV]dehiotu ,.34MVW`efv}*./255[<=<'Y'['~'''''O*P*V*s*******33333/Ƹ@X'`TLh ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.h ^`hH.h ^`hH.h pL^p`LhH.h @ ^@ `hH.h ^`hH.h L^`LhH.h ^`hH.h ^`hH.h PL^P`LhH.X'`T/ a o 13UTcWm&$3<{ >T4CXDiH]\OKVsWd!e] f kZyl9|- _vh"yaYm=N! !sGr0<2,#M65j33@3333 3XX X XXXX X"X&X0X2XXUnknownG.[x Times New Roman5Symbol3. .[x Arial7..{$ CalibriA$BCambria Math"qh3sYs ( (!n2033 3qHP $P]\O2!xx kabanetsRePack by Diakov  Oh+'0d   , 8DLT\ kabanetsNormalRePack by Diakov3Microsoft Office Word@G@Z8g@k ՜.+,0 hp|  HP(3     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&()*+,-.3Root Entry F+l5Data EB1TablecWordDocument4SummaryInformation(DocumentSummaryInformation8'CompObjr  F Microsoft Word 97-2003 MSWordDocWord.Document.89q